FDA Approved: EPLERENONE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for EPLERENONE submitted by Mylan Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction
• Hypertension

Drugs mentioned

• eplerenone (eplerenone)

Snippet

SUPPL AP for EPLERENONE (EPLERENONE)